Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.10.24
2019年果真刊行公司债券(第一期)召募说明书摘要(面向及格投资者)
2019.10.24
2019年果真刊行公司债券(第一期)召募说明书(面向及格投资者)
2019.10.24
2019年面向及格投资者果真刊行公司债券(第一期)刊行通告
2019.10.24
2019年果真刊行公司债券(第一期)信用评级报告
2019.10.15
2019年前三季度业绩预告
2019.10.09
关于参股公司新药临床试验希望的提醒性通告
2019.09.27
关于“16Z6尊龙”回售申报情形的通告
2019.09.24
关于“16Z6尊龙”票面利率调解暨投资者回售实验步伐第三次提醒性通告
2019.09.23
关于“16Z6尊龙”票面利率调解暨投资者回售实验步伐第二次提醒性通告
2019.09.20
关于“16Z6尊龙”票面利率调解暨投资者回售实验步伐第一次提醒性通告
第一页
上一页
39
40
41
42
43
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】